Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05107856
Title A Study of PRT1419 Injection in Patients With Relapsed/Refractory Hematologic Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Prelude Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mid Florida Hematology and Oncology Center Orange City Florida 32763 United States Details
AdventHealth Bone and Marrow Transplant Center Orlando Florida 32804 United States Details
American Oncology Partners of Maryland, PA Bethesda Maryland 20817 United States Details
New Jersey Center for Cancer Research Brick New Jersey 08724 United States Details
Memorial Sloan Kettering Cancer Center - Main Campus New York New York 10065 United States Details
North Shore Hematology Oncology Associates. DBA New York Cancer and Blood Specialists Port Jefferson Station New York 11776 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field